Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
28S ribosomal RNA (rRNA) is a structural component of the large subunit (LSU) of eukaryotic cytoplasmic ribosomes. It plays a critical role in protein synthesis as part of the ribosome, acting as a scaffold for ribosomal proteins and participating directly in catalyzing peptide bond formation. The eukaryotic nuclear 28S rRNA (with its adjacent 5.8S rRNA on the 5' side) serves as the functional homologue to prokaryotic (bacterial/archaeal) 23S rRNA and mitochondrial 16S rRNAs. Targeting processes involving biogenesis or function of this molecule has been explored for anti-cancer therapies due to cancer cells’ dependence on increased protein synthesis capacity via enhanced ribosome production.
Targeting ribosome biogenesis or function to inhibit protein synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 28S ribosomal RNA.